GreenPower's First Commercial Delivery in New Mexico of EV Star Passenger Vans to The Hive Day Care Centers

GreenPower Motor Company (NASDAQ: GP) said it completed the fourth tranche of a preferred share financing, issuing 1,500 Series A Convertible Preferred Shares in a private placement for gross proceeds of US$1.425 million. Shares convert into common stock at a rate tied to stated value plus 125% of the prior day’s NASDAQ closing price. A 5% placement fee applies.

GreenPower Motor Company (NASDAQ: GP) said it completed the third tranche of a preferred-share financing on June 30, 2026, issuing 1,500 Series A Convertible Preferred Shares for gross proceeds of $1.425M. The company and investor amended the agreement to increase the stated value issuable by $2M. Conversion terms reference stated value plus amounts and 125% of prior-day NASDAQ close.

GreenPower Motor Co. (NASDAQ:GP) reported a 40.5% drop in short interest in May, to 145,787 shares as of May 15 from 244,992 on April 30. Short interest was about 4.0% of shares, with a short-interest ratio of 0.7 days. On Thursday, GP traded at $1.13. Analysts cited include Weiss Ratings (sell e+) and BTIG (neutral).

Bristol-Myers Squibb (BMY) reported positive Phase 3 trial results for Zenbexus in treating multiple myeloma, showing superior MRD-negative complete response rates. The data, published in The Lancet Oncology, validate BMS's CELMoD platform. BMY raised its 2026 revenue guidance to $49.0–$50.0 billion and non-GAAP EPS to $6.75–$7.00, despite increased R&D and commercialization costs. The company aims to offset legacy portfolio revenue decay with new growth drivers like Zenbexus.

Novo Nordisk (NVO) partnered with Nanexa AB to develop long-acting injectables for obesity and diabetes, extending dosing to monthly or quarterly. The deal includes €1.165B in payments. Novo reported 11% CER growth in adjusted operating profit for Q2 2026 and raised its full-year outlook. The collaboration aims to enhance patient retention and defend market share, but carries execution risks and upfront costs.

Meta launched the Meta Enterprise Platform, hiring MongoDB's former CEO, Chirantan Desai, to lead it. The platform includes four AI tools, competing with OpenAI and Microsoft. Meta plans to invest $600 billion in US AI infrastructure by 2028. The platform is not yet available in the UK or EU due to regulatory concerns.